Form 4: Encompass Health Director John Chidsey Reports Stock Acquisitions

Sentiment:

SEC Form 4


Director John Chidsey reports acquisition of Encompass Health common stock through dividend reinvestment and deferred stock investment plan.

Summary

  • John Chidsey, a director of Encompass Health Corp, reported acquiring additional shares of common stock.
  • On April 15, 2024, 176 shares were acquired through the reinvestment of dividends from restricted stock units (RSUs).
  • On April 16, 2024, 234 shares were acquired at a weighted average price of $79.52 through the Directors Deferred Stock Investment Plan.
  • Following these transactions, Chidsey directly owns 162,826 shares of Encompass Health common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the director is increasing their stake in the company, indicating confidence. However, the transactions are part of standard compensation plans, so the impact is limited.

Positives

  • The director's participation in the dividend reinvestment and deferred stock investment plan demonstrates confidence in the company's future.

Industry Context

Directors' stock acquisitions are generally viewed positively as they align management's interests with those of shareholders. Dividend reinvestment plans are common mechanisms for directors to increase their stake in the company.

Comparison to Industry Standards

  • Director stock ownership is a common practice across publicly traded companies.
  • Deferred compensation plans are frequently used to attract and retain board members.
  • The level of stock ownership and participation in such plans varies widely depending on the company's size, industry, and compensation policies.

Stakeholder Impact

  • The director's stock acquisitions could have a slightly positive impact on shareholder sentiment.

Key Dates

DateDescription
11/01/2007Effective date of the Directors Deferred Stock Investment Plan.
04/15/2024Acquisition of 176 shares through dividend reinvestment at $0 per share.
04/15/2024Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $80.73.
04/16/2024Acquisition of 234 shares through the Directors Deferred Stock Investment Plan at an average price of $79.52.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.